High doses of opioid reversal spray are no better than lower doses in the field 

A high-dose version of the opioid-reversal spray naloxone, manufactured by Hikma Pharmaceuticals, did not result in increased survival compared with lower-dose versions of the drug when administered in emergencies by…

Continue ReadingHigh doses of opioid reversal spray are no better than lower doses in the field